Home
Dividends Analysis
REITs Analysis
Real Estate Analysis
Summary
Sabra Health Care REIT is a 'Buy' with a near 6% yield and 13x forward P/FFO, supported by favorable demographics and industry supply constraints.
SBRA's Q1 2026 normalized FFO grew 9% YoY, driven by 14.4% same-store SHOP NOI growth and robust occupancy gains.
Management is aggressively deploying capital into SHOP-focused acquisitions at 8% initial cash yields, with a strong pipeline and mostly fixed operating expenses enabling positive operating leverage.
SBRA's healthy balance sheet and improving fundamentals support continued growth potential.
Looking for a portfolio of ideas like this one? Members of iREIT®+HOYA Capital get exclusive access to our subscriber-only portfolios. Learn More »
Vivek Vishwakarma/iStock via Getty Images
Buying common-sense stocks when they are undervalued can be a great strategy.…